Article
Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
Circulation. Cardiovascular genetics - 1 Apr 2014
Alves Marco L, Dias Fernando A L, Gaffin Robert D, Simon Jillian N, Montminy Eric M, Biesiadecki Brandon J, Hinken Aaron C, Warren Chad M, Utter Megan S, Davis Robert T, Sakthivel Sadayappan, Robbins Jeffrey, Wieczorek David F, Solaro R John, Wolska Beata M
Abstract excerpt
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a common genetic disorder caused mainly by mutations in sarcomeric proteins and is characterized by maladaptive myocardial hypertrophy, diastolic heart failure, increased myofilament Ca(2+) sensitivity, and high susceptibility to sudden death. We tested the following hypothesis: correction of the increased myofilament sensitivity can delay or prevent the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
